Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2013; 109(01): 3-4
DOI: 10.1160/TH12-11-0835
DOI: 10.1160/TH12-11-0835
Invited Editorial Focus
Perioperative anticoagulation in device implantation: Benefitting the uninterrupted
Authors
Further Information
Publication History
Received:
19 November 2012
Accepted:
19 November 2012
Publication Date:
25 November 2017 (online)
Editorial Focus on: Feng et al. Thromb Haemost 2012; 108: 1124–1131.
-
References
- 1 Wysokinski WE, McBane 2nd RD. Periprocedural bridging management of anticoagulation. Circulation 2012; 126: 486-490. DOI:10.1161/CIRCULATIONAHA.112.092833.
- 2 Lip GY, Andreotti F, Fauchier L. et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive summary of a position document from the european heart rhythm association [EHRA], endorsed by the european society of cardiology [ESC] working group on thrombosis. Thromb Haemost 2011; 106: 997-1011. DOI:10.1160/TH11-10-0690.
- 3 Chen S, Liu J, Pan W. et al. Thromboembolic events during the perioperative period in patients undergoing permanent pacemaker implantation. Clin Cardiol 2012; 35: 83-87. DOI:10.1002/clc.21955.
- 4 Douketis JD. Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”. Thromb Haemost 2012; 108: 210-212. DOI:10.1160/TH12-04-0236.
- 5 Spyropoulos AC. Pro: “Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery”. Thromb Haemost 2012; 108: 213-216. DOI:10.1160/TH12-04-0217.
- 6 Feng L, Li Y, Li J. et al. Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices. A meta-analysis. Thromb Haemost 2012; 108: 1124-1131. DOI:10.1160/TH12-07-0498.
- 7 Ahrens I, Lip GY, Peter K. New oral anticoagulant drugs in cardiovascular disease. Thromb Haemost 2010; 104: 49-60. DOI:10.1160/TH09-05-0327.
- 8 Ahrens I, Lip GY, Peter K. What do the re-ly, averroes and rocket-af trials tell us for stroke prevention in atrial fibrillation?. Thromb Haemost 2011; 105: 574-578. DOI:10.1160/TH10-12-0808.
- 9 Pengo V, Crippa L, Falanga A. et al. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the italian federation of thrombosis centers (FCSA). Thromb Haemost 2011; 106: 868-876. DOI:10.1160/TH11-05-0358.
- 10 van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127. DOI:10.1160/TH09-11-0758.
- 11 Huisman MV, Lip GY, Diener HC. et al. Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice. Thromb Haemost 2012; 107: 838-847. DOI:10.1160/TH11-10-0718.
- 12 Omran H, Bauersachs R, Rubenacker S. et al. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre bnk online bridging registry (border). Thromb Haemost 2012; 108: 65-73. DOI:10.1160/TH11-12-0827.
- 13 Siegal D, Yudin J, Kaatz S. et al. Periprocedural heparin bridging in patients receiving vitamin k antagonists: Systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126: 1630-1639. DOI:10.1161/CIRCULATIONAHA.112.105221.
- 14 Gallego P, Apostolakis S, Lip GY. Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. Circulation 2012; 126: 1573-1576. DOI:10.1161/CIRCULATIONAHA.112.135681.
- 15 de Bono J, Nazir S, Ruparelia N. et al. Perioperative management of anticoagulation during device implantation-the uk perspective. Pacing Clin Electrophysiol 2010; 33: 389-393. DOI:10.1111/j.1540-8159.2009.02683.x.
- 16 Lip GY, Proclemer A, Dagres N. et al. Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. Europace 2012; 14: 741-744. DOI:10.1093/europace/eus105.
- 17 Di Biase L, Burkhardt JD, Mohanty P. et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio. Circulation 2010; 121: 2550-2556. DOI:10.1161/CIRCULATIONAHA.109.921320.